Table 2. Millar Conductance Catheter Analyses Without LV Systolic Parameters.

	Control (n = 8)	Linagliptin (n = 7)	Empagliflozin (n = 7)	Combination (n = 6)
P max (mm Hg)	91 ± 53	81 ± 8	75 ± 26	98 ± 38
P min (mm Hg)	10 ± 19	6 ± 6	5 ± 5	9 ± 4
V max (mL)	0.038 ± 0.009	0.041 ± 0.010	0.035 ± 0.009	0.048 ± 0.008
V min (mL)	0.027 ± 0.007	0.029 ± 0.007	0.024 ± 0.008	0.032 ± 0.009
ESP (mm Hg)	85 ± 54	78 ± 9	69 ± 27	94 ± 39
ESV (mL)	0.028 ± 0.008	0.030 ± 0.007	0.024 ± 0.008	0.034 ± 0.010
EDP (mm Hg)	11 ± 19	8 ± 6	6 ± 5	10 ± 5
EDV (mL)	0.037 ± 0.008	0.040 ± 0.008	0.035 ± 0.009	0.047 ± 0.008
HR (beats/min)	449 ± 44	471 ± 25	429 ± 41	459 ± 78
Ea (mm Hg/mL)	9,156 ± 5,541	7,344 ± 2,907	7,831 ± 5,494	5,564 ± 2,280
tau (ms)	16 ± 15	10 ± 3	13 ± 6	11 ± 6

LV: left ventricular; P max: maximum pressure; P min: minimum pressure; V max: maximum volume; V min: minimum volume; ESP: end-systolic pressure; ESV: end-systolic volume; EDP: end-diastolic pressure; EDV: end-diastolic volume; HR: heart rate; Ea: arterial elastance; tau: LV diastolic time constant.